drugset / Trial / NCT06571591
Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase 3 study to assess the Efficacy and Safety of CT-L03-301 in Type 2 Diabetes Patients with Insufficient Glycemic Control with Metformin and Empagliflozin Combination Therapy.
Timeline
- Start
- 2024-08-27
- Primary completion
- 2026-04-16
- Completion
- 2026-05-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pioglitazone | Small molecule | — | Oral |
| Comparator | Empagliflozin | Small molecule | — | Oral |
| Comparator | Metformin | Small molecule | — | Oral |